Aspiro Therapeutics Selected to Present at 2025 BIO Startup Stadium
Tucson, Arizona / May 28, 2025 — Aspiro Therapeutics, a preclinical-stage biopharmaceutical company pioneering the development of groundbreaking, disease-modifying therapies for obstructive lung diseases, today announced its selection to present at the BIO 2025 Startup Stadium, part of the BIO International Convention taking place June 17 to 20 in Boston, Massachusetts. Aspiro will present its […]